Small molecules that specifically inhibit PI3Kγ block disease in mouse models of arthritis and lupus (pages 936–943).
References
Deane, J.A. & Fruman, D.A. Annu. Rev. Immunol. 22, 563–598 (2004).
Vanhaesebroeck, B., Ali, K., Bilancio, A., Geering, B. & Foukas, L.C. Trends Biochem. Sci. 30, 194–204 (2005).
Camps, M. et al. Nat. Med. 11, 936–943 (2005).
Barber, D.F. et al. Nat. Med. 11, 933–935 (2005).
Knight, Z.A. et al. Bioorg. Med. Chem. 12, 4749–4759 (2004).
Sasaki, T. et al. Science 287, 1040–1046 (2000).
Hirsch, E. et al. Science 287, 1049–1053 (2000).
Li, Z. et al. Science 287, 1046–1049 (2000).
Siegel, R.M., Chan, F.K., Chun, H.J. & Lenardo, M.J. Nat. Immunol 1, 469–474 (2000).
Vivanco, I. & Sawyers, C.L. Nat. Rev. Cancer 2, 489–501 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohashi, P., Woodgett, J. Modulating autoimmunity: pick your PI3 kinase. Nat Med 11, 924–925 (2005). https://doi.org/10.1038/nm0905-924
Issue Date:
DOI: https://doi.org/10.1038/nm0905-924
- Springer Nature America, Inc.
This article is cited by
-
Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis
Kidney International (2012)
-
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity
Immunologic Research (2011)
-
New drug for autoimmune diseases
Nature Reviews Immunology (2005)